GENSCI ORTHOBIOLOGICS INC has a total of 16 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets medical technology, pharmaceuticals and macromolecular chemistry and polymers are POLYGANICS IP B V, GATT TECH B V and INNOVATIVE SURFACE TECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Macromolecular chemistry and polymers | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Kay John F | 7 |
#2 | Clokie Cameron M L | 5 |
#3 | Eisch John J | 4 |
#4 | Coulson Richard | 3 |
#5 | King Edward | 3 |
#6 | Borden Mark | 3 |
#7 | Jefferies Steven R | 2 |
#8 | Chen Charles C | 2 |
#9 | Jeffries Steven R | 1 |
#10 | Edward King | 1 |
Publication | Filing date | Title |
---|---|---|
AU2002357898A1 | End-capped polyalkylene glycols and compositions containing such compounds | |
US6180606B1 | Compositions with enhanced osteogenic potential, methods for making the same and uses thereof | |
US6180605B1 | Composition with enhanced osteogenic potential, method for making the same and therapeutic uses thereof | |
US6309659B1 | Reverse phase connective tissue repair composition | |
US6311690B1 | Bone repair material and delayed drug delivery system |